Minnie Miñoso, quien pasó parte de 12 temporadas con los Chicago White Sox, es uno de los 10 jugadoros en la boleta de la Era de los Días Dorados para el Salón de la Fama del Béisbol. Los resultados se darán a conocer el domingo.
Pfizer says it could give more than half of the world’s population access to the covid-19 treatment.
Licensed practical nurse Yokasta Castro, of Warwick, R.I., draws a Moderna COVID-19 vaccine into a syringe at a mass vaccination clinic, Wednesday, May 19, 2021, at Gillette Stadium, in Foxborough, Mass. | Steven Senne/AP
A panel of U.S. health advisers on Tuesday narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the virus.
The 13-10 vote puts the simple, at-home treatment, called molnupiravir, on track for FDA approval.
On Friday, the Food and Drug Administration (FDA) officially announced its recommendation for COVID-19 booster shots for all American adults. This is great news, as the U.S. faces not only the continued spread of the delta variant, but also potential outbreaks over the winter. Unfortunately, the agency's track record up to this point could seriously jeopardize the rollout.
Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks.
A Food and Drug Administration panel voted 13-10 that the Merck COVID-19 pill’s benefits outweigh its risks, including potential birth defects if used during pregnancy.